9 March 2022 - Trodelvy is accepted for use in metastatic triple negative breast cancer. patients who have already received two ...
7 March 2022 - Diurnal provides an update on the status of reimbursement of Efmody (modified release hydrocortisone) for NHS ...
7 March 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
9 February 2022 - The new, at home oral treatment has been developed for adults in Scotland living with relapsing-remitting multiple ...
9 February 2022 - SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy ...
8 February 2022 - The medicines have been approved for use by the Scottish Medicines Consortium. ...
7 February 2022 - Advice on six new medicines for use in conditions including a rare lung cancer caused by ...
23 January 2022 - A breast cancer drug that can melt away tumours in weeks has been given the green ...
17 January 2022 - Advice on four new medicines for use in conditions including advanced breast cancer and non-small cell ...
14 December 2021 - Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland ...
13 December 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has published ...
10 November 2021 - Three new cancer drugs have been given the go-ahead by the SMC for routine use in ...
10 November 2021 - Janssen has announced that the SMC have accepted Ponvory (ponesimod) within NHS Scotland, as a treatment for ...
8 November 2021 - The Scottish Medicines Consortium which advises on newly licensed medicines for use by NHSScotland has published ...
13 October 2021 - The SMC has recommended Cabometyx (cabozantinib) plus Opdivo (nivolumab) for use by via NHS Scotland for ...